| Literature DB >> 27140496 |
Yasuo Oowatari1, Tetsuro Ogawa1, Takuya Katsube1, Kiyohisa Iinuma2, Hisae Yoshitomi3, Ming Gao3.
Abstract
Hypertrophy of adipocytes in obese adipose tissues causes metabolic abnormality by adipocytokine dysregulation, which promotes type 2 diabetes mellitus, hypertension, and dyslipidemia. We investigated the effects of wasabi (Wasabia japonica Matsum) leaf extracts on metabolic abnormalities in SHRSP.Z-Leprfa/IzmDmcr rats (SHRSP/ZF), which are a model of metabolic syndrome. Male SHRSP/ZF rats aged 7 weeks were divided into two groups: control and wasabi leaf extract (WLE) groups, which received water or oral treatment with 4 g/kg/day WLE for 6 weeks. WLE improved the body weight gain and high blood pressure in SHRSP/ZF rats, and the plasma triglyceride levels were significantly lower in the WLE group. Adipocyte hypertrophy was markedly prevented in adipose tissue. The expression of PPARγ and subsequent downstream genes was suppressed in the WLE group adipose tissues. Our data suggest that WLE inhibits adipose hypertrophy by suppressing PPARγ expression in adipose tissue and stimulating the AMPK activity by increased adiponectin.Entities:
Keywords: AMPK; PPARγ; SHRSP.Z-Leprfa/IzmDmcr rat; adipocyte hypertrophy; wasabi leaf extract
Mesh:
Substances:
Year: 2016 PMID: 27140496 DOI: 10.1080/09168451.2016.1179093
Source DB: PubMed Journal: Biosci Biotechnol Biochem ISSN: 0916-8451 Impact factor: 2.043